The Valley Desk

ArticleScience advancesPublished

Glutamine antagonist DRP-104 suppresses tumor growth and enhances response to checkpoint blockade in KEAP1 mutant lung cancer

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Princeton University. Affiliation source

Publication record

Type
Article
Venue
Science advances
Published
Subject terms
Humans; Lung Neoplasms; Glutamine; Enzyme Inhibitors; Mutation; NF-E2-Related Factor 2; Kelch-Like ECH-Associated Protein 1
PubMed ID
38536921
PubMed Central ID
PMC10971495
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal